Skip to main content

CORRECTION article

Front. Pharmacol., 07 November 2022
Sec. Ethnopharmacology
Volume 13 - 2022 | https://doi.org/10.3389/fphar.2022.1073679

Corrigendum: Exploiting curcumin synergy with natural products using quantitative analysis of dose-effect relationships in an experimental in vitro model of osteoarthritis

This article is a correction to:

  1. Exploiting Curcumin Synergy With Natural Products Using Quantitative Analysis of Dose–Effect Relationships in an Experimental In Vitro Model of Osteoarthritis

    1. Read original article
Angela D&#x;Ascola&#x;Angela D’Ascola1†Natasha Irrera&#x;Natasha Irrera1†Roberta EttariRoberta Ettari2Alessandra BittoAlessandra Bitto1Giovanni PallioGiovanni Pallio1Federica ManninoFederica Mannino1Marco AtteritanoMarco Atteritano1Giuseppe M. CampoGiuseppe M. Campo1Letteria MinutoliLetteria Minutoli1Vincenzo ArcoraciVincenzo Arcoraci1Violetta SquadritoVioletta Squadrito1Giacomo PiccioloGiacomo Picciolo1Francesco Squadrito Francesco Squadrito1*Domenica AltavillaDomenica Altavilla3
  • 1Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
  • 2Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Italy
  • 3Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy

A Corrigendum on
Exploiting curcumin synergy with natural products using quantitative analysis of dose-effect relationships in an experimental in vitro model of osteoarthritis

by D’Ascola A, Irrera N, Ettari R, Bitto A, Pallio G, Mannino F, Atteritano M, Campo GM, Minutoli L, Arcoraci V, Squadrito V, Picciolo G, Squadrito F and Altavilla D (2019). Front. Pharmacol. 10:01347. doi: 10.3389/fphar.2019.01347

In the published article, the Conflict of Interest statement was incorrectly filed. The correct Conflict of Interest statement appears below.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Conflict of Interest

Author DA is co-inventor on a patent related to curcumin synergy in anti-inflammatory formulations. Author FS has received research support from Primus Pharmaceuticals for work on genistein.

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: synergy, curcumin, flavocoxid, beta-caryophyllene, inflammation

Citation: D’Ascola A, Irrera N, Ettari R, Bitto A, Pallio G, Mannino F, Atteritano M, Campo GM, Minutoli L, Arcoraci V, Squadrito V, Picciolo G, Squadrito F and Altavilla D (2022) Corrigendum: Exploiting curcumin synergy with natural products using quantitative analysis of dose-effect relationships in an experimental in vitro model of osteoarthritis. Front. Pharmacol. 13:1073679. doi: 10.3389/fphar.2022.1073679

Received: 18 October 2022; Accepted: 19 October 2022;
Published: 07 November 2022.

Approved by:

Frontiers Editorial Office Frontiers Media SA, Switzerland

Copyright © 2022 D’Ascola, Irrera, Ettari, Bitto, Pallio, Mannino, Atteritano, Campo, Minutoli, Arcoraci, Squadrito, Picciolo, Squadrito and Altavilla. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Francesco Squadrito, ZnNxdWFkcml0b0B1bmltZS5pdA==

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.